Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

Capecitabine 825 mg/m2 orally twice-daily, 5 days a week for a total of 28 days, given with radiation therapy

1.8 Gy/day, 5 days a week for a total of 28 days, given with Capecitabine

oxaliplatin 85 mg/m2, leucovorin 400 mg/m2 and fluorouracil 400 mg/m2 IV, fluorouracil 2400 mg/m2 IV (a 46 hrs CI), day 1 of each treatment cycle, every 2 weeks, given with nivolumab

Nivolumab 240mg IV, day 1 of each treatment cycle, every two weeks, given with mFOLFOX6